GlassScriptPhysician profile
Timothy Hartzler
NPI 1417400458
$2,313.77
in general payments reported to CMS, 2019-2025
17 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $572 · 2022: $1,561 · 2023: $61.01 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $181.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $180.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,055.70 | 2021-2023 | |
| Celgene Corporation | $314.09 | 2021-2023 | Zeposia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $248.38 | 2021-2022 | |
| Radius Health, INC. | $119.69 | 2025 | Tymlos |
| Qol Medical, LLC | $105.88 | 2021-2022 | |
| Braintree Laboratories, INC. | $88.91 | 2022 | |
| Pfizer INC. | $84.47 | 2021-2022 | |
| Daiichi Sankyo INC. | $59.04 | 2021-2022 | |
| Nestle Healthcare Nutrition INC. | $46.62 | 2021-2022 | |
| Janssen Biotech, INC. | $39.41 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $35.68 | 2021-2022 | |
| Intra-Sana Laboratories | $32.46 | 2022 | |
| Apollo Endosurgery US INC | $28.03 | 2022 | |
| Ardelyx, INC. | $15.94 | 2022 | |
| Ironwood Pharmaceuticals, INC | $15.26 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $13.66 | 2021 | |
| Organon LLC | $10.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Hartzler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.